Literature DB >> 27924367

Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.

Jihye Park1, Jae Hee Cheon2,3, Yong Eun Park1, Yoon Jee Lee1, Hyun Jung Lee1,4, Soo Jung Park1,4, Sung Pil Hong1,4, Tae Il Kim1,4, Won Ho Kim1,4.   

Abstract

BACKGROUND: Intestinal Behçet's disease (BD) can cause acute lower gastrointestinal bleeding, which is sometimes fatal. AIM: We aimed to identify the risk factors and outcomes of acute lower gastrointestinal bleeding and factors associated with rebleeding in intestinal BD patients.
METHODS: Of the total of 588 intestinal BD patients, we retrospectively reviewed the medical records of 66 (11.2%) patients with acute lower gastrointestinal bleeding and compared them with those of 132 matched patients without bleeding.
RESULTS: The baseline characteristics were comparable between the bleeding group (n = 66) and the non-bleeding group (n = 132). On multivariate analysis, the independent factors significantly associated with lower gastrointestinal bleeding were older age (>52 years) (hazard ratio [HR] 2.2, 95% confidence interval [CI] 1.058-4.684, p = 0.035) and a nodular ulcer margin (HR 7.1, 95% CI 2.084-24.189, p = 0.002). Rebleeding occurred in 23 patients (34.8%). Female patients (p = 0.044) and those with previous use of corticosteroids or azathioprine (p = 0.034) were more likely to develop rebleeding. On multivariate analysis, only use of steroids or azathioprine was significantly associated with rebleeding (HR 3.2, 95% CI 1.070-9.462, p = 0.037).
CONCLUSIONS: Age >52 years and the presence of a nodular margin of the ulcer were found to be related to increased risk of bleeding in patients with intestinal BD. Rebleeding is not uncommon and not effectively prevented with currently available medications. Further studies are warranted to identify effective measures to decrease rebleeding in intestinal BD.

Entities:  

Keywords:  Behçet’s disease; Gastrointestinal hemorrhage; Outcome; Rebleeding; Risk factor

Mesh:

Year:  2016        PMID: 27924367     DOI: 10.1007/s00384-016-2728-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  36 in total

1.  [Multiple small bowel perforations due to Behcet's disease].

Authors:  Tevfik Eker; Aydan Eroğlu
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2015-07

2.  [Diagnosis of intestinal Behçet's disease].

Authors:  Jae Hee Cheon; Sung Jae Shin; Sang Woo Kim; Kang Moon Lee; Joo Sung Kim; Won Ho Kim
Journal:  Korean J Gastroenterol       Date:  2009-03

Review 3.  Gastrointestinal Behçet's disease: a review.

Authors:  Wasseem Skef; Matthew J Hamilton; Thurayya Arayssi
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 4.  An update on the diagnosis, treatment, and prognosis of intestinal Behçet's disease.

Authors:  Jae Hee Cheon; Won Ho Kim
Journal:  Curr Opin Rheumatol       Date:  2015-01       Impact factor: 5.006

5.  Characteristics of patients with intestinal Behçet's disease requiring treatment with immunosuppressants or anti-TNFα antibody.

Authors:  Yoshitaka Kimura; Kurumi Asako; Hirotoshi Kikuchi; Hajime Kono
Journal:  Mod Rheumatol       Date:  2015-07-18       Impact factor: 3.023

Review 6.  Treatment of IBD: where we are and where we are going.

Authors:  Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2014-12-09       Impact factor: 10.864

7.  Efficacy of infliximab in intestinal Behçet's disease: a Korean multicenter retrospective study.

Authors:  Jin Ha Lee; Jae Hee Cheon; Seong Woo Jeon; Byong Duk Ye; Suk-Kyun Yang; Young-Ho Kim; Kang-Moon Lee; Jong Pil Im; Joo Sung Kim; Chang Kyun Lee; Hyo Jong Kim; Eun Young Kim; Kyeong Ok Kim; Byung Ik Jang; Won Ho Kim
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

8.  Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.

Authors:  Robert V Bryant; Daniel C Burger; Joseph Delo; Alissa J Walsh; Sally Thomas; Axel von Herbay; Otto C Buchel; Lydia White; Oliver Brain; Satish Keshav; Bryan F Warren; Simon P L Travis
Journal:  Gut       Date:  2015-05-18       Impact factor: 23.059

9.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

Review 10.  Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?

Authors:  Duk Hwan Kim; Jae Hee Cheon
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

View more
  6 in total

Review 1.  Updated treatment strategies for intestinal Behçet's disease.

Authors:  Yong Eun Park; Jae Hee Cheon
Journal:  Korean J Intern Med       Date:  2017-12-08       Impact factor: 2.884

Review 2.  Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.

Authors:  Jihye Park; Jae Hee Cheon
Journal:  Gut Liver       Date:  2018-11-15       Impact factor: 4.519

3.  Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.

Authors:  Ippei Miyagawa; Kazuhisa Nakano; Shigeru Iwata; Shingo Nakayamada; Kazuyoshi Saito; Kentaro Hanami; Shunsuke Fukuyo; Satoshi Kubo; Akio Kawabe; Yusuke Miyazaki; Yoshiya Tanaka
Journal:  Arthritis Res Ther       Date:  2019-06-22       Impact factor: 5.156

4.  Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet's disease in the Shanghai Adamantiades-Behçet's disease database: a prospective cohort study.

Authors:  Liang Zhang; Yun Tian; Jing-Fen Ye; Chen-Hong Lin; Jian-Long Guan
Journal:  Orphanet J Rare Dis       Date:  2019-11-28       Impact factor: 4.123

5.  Efficacy and Safety of Anti-Tumor Necrosis Factor-Alpha Agents for Patients with Intestinal Behcet's Disease: A Systematic Review and Meta-Analysis.

Authors:  Qingfeng Zhang; Chunyan Ma; Rongrong Dong; Weizhen Xiang; Meiqi Li; Zhenzhen Ma; Qingrui Yang
Journal:  Yonsei Med J       Date:  2022-02       Impact factor: 2.759

Review 6.  Imaging of intestinal vasculitis focusing on MR and CT enterography: a two-way street between radiologic findings and clinical data.

Authors:  Mehrnam Amouei; Sara Momtazmanesh; Hoda Kavosi; Amir H Davarpanah; Ali Shirkhoda; Amir Reza Radmard
Journal:  Insights Imaging       Date:  2022-09-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.